A large self-funded employer partnered with Northwind Health to deploy a high-touch, clinically-driven diabetes program — and the results speak for themselves.
Over the course of the 2025 program year, the client saw clinical outcomes that most employers only read about — combined with financial results that justify every dollar of program investment.
The Challenge
In 2024, employees had above average health risk and high turnover — a combination that makes chronic disease management both critical and complicated.
Diabetes wasn’t just a health issue — it had become a cost crisis. Half of all prescription spend was tied to diabetes, with a 39% spike in prescription costs year over year. Twenty percent annual increases in diabetes-related care had become the norm. But the spending wasn’t translating into better health. Costs were climbing, and members were still getting sicker.
The status quo wasn’t sustainable. It was time for a different approach entirely.
